Baird analyst Rob Oliver downgrades Adobe (NASDAQ:ADBE) from Outperform to Neutral and lowers the price target from $450 to $355.
ATAI Life Sciences Q2 EPS $(0.24) Misses $(0.23) Estimate, Sales $170.00K
ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.23) by 4.35 percent. This is a 35.14 percent increase over losses of $(0.37) per share